Clinical Trials

Clinical trials and studies about imaging technology can be found on this channel.

Immunis, Inc. has announced that a partnership with Springbok Analytics to implement their MRI-based AI muscle analysis technology in its Phase 1/2a Clinical Trial, assessing the efficacy of its novel secretome therapeutic (IMMUNA) in targeting sarcopenia.
News | Radiology Business
Immunis Partners with Springbok Analytics on MRI-based AI Muscle Analysis Technology

July 25, 2024 — Immunis, Inc., a clinical-stage biotech developing groundbreaking secretome therapeutics for age and ...

Time July 25, 2024
arrow
Whole-body MRI maker Prenuvo has announced the launch of a clinical research study, Project Hercules, which aims to assess the accuracy of whole-body MRI (WB-MRI) screening in predicting clinically significant diagnoses in the general population.
News | Clinical Trials
Prenuvo Announces Unprecedented Large-Scale Clinical Study of General Population Whole-Body MRI Screening

June 27, 2024 — Prenuvo, which makes whole-body MRI screening for early cancer detection and other diseases, has ...

Time June 27, 2024
arrow
A new study led by researchers at Emory AI.Health, published in the Journal of Computers in Medicine and Biology, sheds light on the significant lung damage caused by severe COVID-19.
News | Artificial Intelligence
Study Applying AI to CT Scans Unveils Lung Damage Severity in COVID-19 Patients

June 11, 2024 — A new study led by researchers at Emory AI.Health, published in the Journal of Computers in Medicine and ...

Time June 11, 2024
arrow
Latest innovations in clinical cancer research discussed at American Society of Clinical Oncology (ASCO) Annual Meeting
News | Breast Imaging
Breakthroughs in Breast Cancer: Susan G. Komen(R) Scholars and Studies Highlighted at ASCO 2024

June 7, 2024 — Scholars and studies funded by Susan G. Komen(R), the world’s leading breast cancer organization ...

Time June 07, 2024
arrow
Latest innovations in clinical cancer research discussed at American Society of Clinical Oncology (ASCO) Annual Meeting
News | Radiopharmaceuticals and Tracers
Shine Technologies Partners with Blue Earth Therapeutics for First Supply of Ilumira from Its New Facility

June 7, 2024 — Shine Technologies, LLC, a pioneer in next-generation fusion-based technology, today announced a new ...

Time June 07, 2024
arrow
RaySearch Laboratories AB announced the release of the latest version of RayCare
News | Oncology Information Management Systems (OIMS)
RaySearch releases RayCare 2024A

May 30, 2024 — RaySearch Laboratories AB announced the release of the latest version of RayCare, the next generation ...

Time May 30, 2024
arrow
Penn Medicine will have a strong presence at the upcoming American Society of Clinical Oncology (ASCO) 2024 Annual Meeting.
News | Clinical Trials
Penn Medicine to Present Multiple Clinical Trial Results at 2024 ASCO Annual Meeting

May 30, 2024 — Researchers from Penn Medicine’s Abramson Cancer Center (ACC) and the Perelman School of Medicine at the ...

Time May 29, 2024
arrow
A new UCLA study found Unfold AI’s precise prediction of prostate margins significantly impacts the success of focal therapy treatments
News | Prostate Cancer
New Study Demonstrates Avenda Health’s Unfold AI to Better Predict Focal Therapy Success by 77% Percent as Compared to Standard Methods

May 13, 2024 — Avenda Health, an AI healthcare company creating the future of personalized prostate cancer care, unveils ...

Time May 13, 2024
arrow
Prospective pilot research study is first of its kind to attempt to quantify the impact of playing, training, and rest over a professional basketball season on musculoskeletal health with a cohort of elite professional basketball players from multiple teams
News | Radiology Imaging
NBA, NBPA, and NGBPU Collaborate with GE HealthCare and MedStar Health on Musculoskeletal and Joint Health Study

May 13, 2024 — National Basketball Association (NBA), the National Basketball Players Association (NBPA), and the Next ...

Time May 13, 2024
arrow
Swedish biotech company Ascelia Pharma has announced its liver imaging drug candidate, Orviglance, significantly improved visualization of focal liver lesions, having successfully met the primary endpoint in the pivotal Phase 3 study, SPARKLE. CEO Magnus Corftizen shown here, offered an update on the first-in-class contrast agent for use in liver MRI in patients with severely impaired kidney function which has been granted FDA Orphan Drug Designation.
News | Contrast Media
Ascelia Pharma Meets Primary Endpoint in Phase 3 Study of Orviglance Liver Imaging Contrast Agent Drug Candidate

May 8, 2024 — Swedish biotech company Ascelia Pharma AB has announced that its liver imaging drug candidate, Orviglance ...

Time May 08, 2024
arrow
CHLA team helps validate guidelines promoting safer pediatric emergency department CT scans
News | Pediatric Imaging
Validated Rules Help Prevent Overuse of CT Scans for Diagnosing Traumatic Head and Abdominal Injuries in Kids

May 2, 2024 — Head and abdominal trauma is a leading cause of death for children. About 1%–2% of children who come to ...

Time May 02, 2024
arrow
The study, led by principal investigator Nitin Ohri, M.D., a professor in Radiation Oncology at the Montefiore Einstein Comprehensive Cancer Center, aims to demonstrate the feasibility of PGHD collection during proton beam radiotherapy for lung cancer
News | Proton Therapy
Koneksa Announces Study with New York Proton Center to Collect Patient-Generated Health Data During Proton Radiotherapy in Lung Cancer

April 29, 2024 — Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, announced today ...

Time April 29, 2024
arrow
Study will assess the clinical utility and workflow benefits of physicians using images acquired by the Swoop Portable MR Imaging system to identify ARIA events in Alzheimer’s patients treated with amyloid-targeting therapy
News | Magnetic Resonance Imaging (MRI)
Leading Institutions Enroll First Alzheimer’s Patients Receiving Amyloid-Targeting Therapy in CARE PMR Study

April 17, 2024 — Hyperfine, Inc., a groundbreaking health technology company that has redefined brain imaging with the ...

Time April 17, 2024
arrow
QTI’s Breast Acoustic CT Scans for mass detection reported results from its second blinded multi-reader multi-case study
News | Clinical Trials
QT Imaging Announces Second Blinded Screening Trial Finding Its Technology Similarly Effective as Digital Breast Tomosynthesis

April 16, 2024 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...

Time April 16, 2024
arrow
Early coronary disease and impaired heart function, with increased coronary vessel wall thickness, in asymptomatic, middle-aged individuals living with HIV has been reported in a new study published today in Radiology: Cardiothoracic Imaging, a journal of the Radiological Society of North America (RSNA).
News | Population Health
New Study Finds Early Coronary Disease, Impaired Heart Function in Asymptomatic People with HIV

April 4, 2024 — A new study found increased coronary vessel wall thickness that was significantly associated with ...

Time April 04, 2024
arrow
Ultrasound (US) images in a 57-year-old female patient with multifocal papillary thyroid carcinoma (PTC).
News | Radiation Oncology
Minimally Invasive Procedure May Spare Patients from Thyroid Surgery

April 2, 2024 — In a 10-center study, microwave ablation offered progression free survival rates and fewer complications ...

Time April 02, 2024
arrow
The Advanced Research Projects Agency for Health (ARPA-H) has appointed American College of Radiology (ACR) Chief Research Officer (CRO) Etta D. Pisano, MD, FACR, senior portfolio lead, to build the agency’s clinical trial portfolio and lead the ARPA-H Advancing Clinical Trials Readiness Initiative.
News | ACR
ARPA-H Appoints American College of Radiology (ACR) Chief Research Officer Etta Pisano, MD, FACR to Lead "Advancing Clinical Trials Readiness" Initiative

March 21, 2024 — The Advanced Research Projects Agency for Health (ARPA-H) has appointed American College of Radiology ...

Time March 21, 2024
arrow
Study represents largest cryoablation study of its kind in the U.S. for early-stage low-risk malignant breast tumors
News | Breast Imaging
IceCure Medical Reports Positive Topline Results From ICE3 Cryoablation Breast Cancer Study

March 20, 2024 — IceCure Medical Ltd., developer of the ProSense System, a minimally-invasive cryoablation technology ...

Time March 20, 2024
arrow
Radiology Advances, the first exclusively open-access journal of the Radiological Society of North America (RSNA), published its first articles
News | RSNA
RSNA ‘Radiology Advances’ Open-Access Journal Goes Live

March 19, 2024 — Radiology Advances, the first exclusively open-access journal of the Radiological Society of North ...

Time March 19, 2024
arrow
Researchers examine social determinants of health, health inequities
News | Breast Imaging
Study Underscores Social Factors of Low Breast Cancer Screening in the US

March 6, 2024 — There is a pressing need to explore and understand which social determinants of health (SDOH) and health ...

Time March 06, 2024
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now